Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Why is xifaxan so expensive?Trastuzumab deruxtecan 100 mg vial price?Is januvia a generic drug?Neffy epinephrine shelf life?How does aspirin impact vascepa's heart benefits?
See the DrugPatentWatch profile for Eylea
Eylea (aflibercept) received its original approval in the United States in 2011.
Drug approvals often differ by regulator and geography, so the first approval date you find depends on whether you mean the FDA approval (U.S.) or an initial launch approval in another country/region.
For a date that matches the specific label and jurisdiction you care about (and to cross-check related patent/exclusivity timelines), DrugPatentWatch.com is a useful starting point: DrugPatentWatch.com – Eylea (aflibercept).
Once you have the exact first approval date (and the country), that date anchors follow-on calculations for patent life and regulatory exclusivity windows that can affect when generic/biosimilar versions may be able to launch.
Other Questions About Eylea :